URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Kevin Walter

Concepts (205)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Brain Neoplasms
15
1994
254
3.510
Why?
Glioma
7
1994
92
2.280
Why?
Gene Expression Regulation, Neoplastic
3
2005
247
1.170
Why?
Neovascularization, Pathologic
3
2004
93
1.090
Why?
Glioblastoma
6
2000
55
1.080
Why?
Carrier Proteins
3
2005
410
0.980
Why?
Membrane Proteins
3
2005
530
0.960
Why?
Endothelium, Vascular
3
2004
401
0.930
Why?
Tumor Markers, Biological
3
2004
221
0.880
Why?
Paclitaxel
4
1994
56
0.840
Why?
Blood-Brain Barrier
3
2003
103
0.790
Why?
Collagen
2
2005
270
0.730
Why?
Hematoma, Subdural, Acute
1
2010
1
0.700
Why?
Decompressive Craniectomy
1
2010
1
0.700
Why?
Matrix Metalloproteinase 14
1
2010
11
0.690
Why?
Spinal Cord Neoplasms
1
2009
18
0.670
Why?
SEER Program
1
2009
51
0.670
Why?
Antigens, Neoplasm
1
2009
105
0.640
Why?
Antigens, CD
1
2009
240
0.600
Why?
Magnesium Sulfate
1
2007
10
0.590
Why?
Brain Ischemia
1
2008
79
0.570
Why?
Magnesium
1
2007
131
0.560
Why?
Drug Delivery Systems
2
2003
59
0.550
Why?
Anticonvulsants
1
2007
96
0.540
Why?
Brain Injuries
1
2007
91
0.520
Why?
Hepatocyte Growth Factor
2
2000
13
0.500
Why?
Microspheres
2
2003
53
0.480
Why?
Biocompatible Materials
2
2003
52
0.460
Why?
Central Nervous System Neoplasms
1
2003
20
0.440
Why?
Radiosurgery
3
2000
73
0.410
Why?
CDC2-CDC28 Kinases
1
2002
10
0.410
Why?
Proto-Oncogene Proteins c-myc
1
2002
46
0.400
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2005
513
0.380
Why?
Cell Cycle
1
2002
247
0.360
Why?
Humans
25
1994
35000
0.360
Why?
Retrospective Studies
7
1995
2167
0.310
Why?
Treatment Outcome
7
1995
2487
0.290
Why?
In Situ Hybridization
2
2005
293
0.280
Why?
DNA-Binding Proteins
1
2002
661
0.280
Why?
Male
14
1994
18870
0.270
Why?
RNA, Messenger
3
2004
1791
0.260
Why?
Up-Regulation
2
2005
344
0.240
Why?
Aged
9
2000
6986
0.240
Why?
Glasgow Coma Scale
3
1997
51
0.240
Why?
Tissue Array Analysis
2
2009
35
0.220
Why?
Middle Aged
9
2000
9461
0.210
Why?
Aged, 80 and over
6
2000
2423
0.210
Why?
Female
10
2000
19061
0.210
Why?
Adult
9
2000
10906
0.200
Why?
Kaplan-Meier Estimate
2
2009
190
0.200
Why?
Brain
4
1994
1161
0.200
Why?
Cell Line, Tumor
2
2003
543
0.200
Why?
Animals
8
1994
15647
0.200
Why?
Adolescent
3
2007
4513
0.190
Why?
Vimentin
1
2011
28
0.190
Why?
Carcinoma, Pancreatic Ductal
1
2011
13
0.190
Why?
Rats, Inbred F344
3
1994
356
0.180
Why?
Analysis of Variance
3
2000
705
0.180
Why?
Pancreatic Neoplasms
1
2011
85
0.180
Why?
Antineoplastic Agents
1
1995
598
0.180
Why?
Aortic Valve Stenosis
1
2010
17
0.180
Why?
Receptors, CXCR
1
2010
4
0.180
Why?
Dacarbazine
1
2010
17
0.170
Why?
Central Nervous System
1
2011
110
0.170
Why?
Peroxidase
1
2010
36
0.170
Why?
Antineoplastic Agents, Alkylating
1
2010
38
0.170
Why?
Xenograft Model Antitumor Assays
1
2009
43
0.170
Why?
Transcription, Genetic
2
2002
795
0.170
Why?
Immunohistochemistry
2
2009
1024
0.170
Why?
Extracellular Matrix Proteins
1
2010
74
0.160
Why?
Culture Media, Conditioned
2
2005
60
0.160
Why?
Reoperation
1
2010
182
0.160
Why?
Mice, Nude
1
2009
178
0.160
Why?
Fluorescent Antibody Technique
1
2009
287
0.160
Why?
Catheterization
1
2010
122
0.160
Why?
Protein-Serine-Threonine Kinases
2
2000
243
0.160
Why?
Chi-Square Distribution
1
2010
320
0.160
Why?
Survival Analysis
6
1994
575
0.160
Why?
Gene Expression
2
2000
723
0.150
Why?
Neoplasm Recurrence, Local
1
2010
272
0.150
Why?
Aneurysm, Ruptured
2
1997
9
0.150
Why?
Cancer Vaccines
1
2007
31
0.150
Why?
Fibroblasts
2
2007
514
0.150
Why?
Mice
2
2008
5900
0.150
Why?
Infant
2
2009
2102
0.150
Why?
Subarachnoid Hemorrhage
2
1997
27
0.150
Why?
Tumor Cells, Cultured
4
1994
871
0.140
Why?
Species Specificity
1
2008
335
0.140
Why?
Child, Preschool
2
2009
2452
0.140
Why?
Interleukin-4
1
2007
160
0.140
Why?
Databases, Factual
1
2007
147
0.140
Why?
Cell Movement
2
2005
352
0.140
Why?
Age Factors
1
2009
1060
0.130
Why?
Mice, Knockout
1
2009
857
0.130
Why?
Laminin
1
2005
45
0.130
Why?
Antineoplastic Agents, Phytogenic
1
2006
38
0.130
Why?
Microcirculation
1
2005
93
0.130
Why?
Proteoglycans
1
2005
89
0.130
Why?
Drug Combinations
1
2005
142
0.130
Why?
Drug Implants
2
1994
18
0.120
Why?
Biological Markers
1
2008
532
0.120
Why?
Young Adult
1
2009
1013
0.120
Why?
Ischemia
1
2005
83
0.120
Why?
RNA Interference
1
2005
122
0.120
Why?
Neoplasm Metastasis
1
2005
219
0.120
Why?
Rats
4
1994
4185
0.120
Why?
RNA, Small Interfering
1
2005
180
0.120
Why?
Child
2
2009
3897
0.120
Why?
Transfection
1
2007
833
0.120
Why?
Vascular Endothelial Growth Factor A
1
2005
192
0.120
Why?
Cohort Studies
1
2007
912
0.110
Why?
Disease Models, Animal
1
2008
908
0.110
Why?
Karnofsky Performance Status
2
2000
15
0.110
Why?
Blotting, Western
1
2005
617
0.110
Why?
Time Factors
3
2000
3047
0.110
Why?
Chromatography, High Pressure Liquid
1
2003
206
0.110
Why?
Mice, Inbred C57BL
1
2008
1613
0.100
Why?
Contact Inhibition
1
2002
4
0.100
Why?
E2F1 Transcription Factor
1
2002
4
0.100
Why?
E2F Transcription Factors
1
2002
4
0.100
Why?
Cyclin-Dependent Kinase 2
1
2002
11
0.100
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2002
30
0.100
Why?
Proportional Hazards Models
1
2003
398
0.100
Why?
S Phase
1
2002
44
0.100
Why?
G1 Phase
1
2002
51
0.100
Why?
Cyclin-Dependent Kinases
1
2002
39
0.100
Why?
Culture Media
1
2002
190
0.100
Why?
RNA
1
2005
395
0.100
Why?
Active Transport, Cell Nucleus
1
2002
98
0.100
Why?
Tumor Suppressor Proteins
1
2002
86
0.090
Why?
Cranial Irradiation
1
2000
13
0.090
Why?
Dose Fractionation
3
2000
57
0.090
Why?
Recombinant Fusion Proteins
1
2002
375
0.090
Why?
Cell Cycle Proteins
1
2002
156
0.090
Why?
Carcinoma, Non-Small-Cell Lung
1
2000
66
0.080
Why?
Cells, Cultured
1
2005
2367
0.080
Why?
Phosphatidylinositol 3-Kinases
1
2000
133
0.080
Why?
Inflammation
1
2003
518
0.080
Why?
Radiotherapy Dosage
3
1995
185
0.080
Why?
Patient Selection
1
2000
197
0.080
Why?
Proto-Oncogene Proteins
1
2000
261
0.080
Why?
Intracranial Aneurysm
1
1997
20
0.070
Why?
Combined Modality Therapy
2
2007
459
0.070
Why?
Neurologic Examination
1
1997
143
0.070
Why?
Lung Neoplasms
1
2000
422
0.070
Why?
Prognosis
3
1997
1030
0.070
Why?
Transcription Factors
1
2002
659
0.070
Why?
Injections, Intralesional
1
1995
12
0.070
Why?
Infusion Pumps, Implantable
1
1995
9
0.070
Why?
Apoptosis
1
2000
782
0.060
Why?
Decanoic Acids
1
1994
5
0.060
Why?
Polyesters
1
1994
6
0.060
Why?
Clinical Trials, Phase II as Topic
1
1994
13
0.060
Why?
Biopolymers
1
1994
11
0.060
Why?
Tissue Distribution
1
1994
228
0.060
Why?
Dose-Response Relationship, Drug
1
1995
1085
0.050
Why?
Clinical Trials as Topic
1
1995
664
0.050
Why?
Signal Transduction
1
2000
1465
0.050
Why?
Pancreatectomy
1
2011
18
0.050
Why?
Prospective Studies
3
1997
1606
0.050
Why?
Follow-Up Studies
2
2000
1757
0.050
Why?
Epithelium
1
2011
223
0.040
Why?
Salvage Therapy
1
2009
56
0.040
Why?
Disease-Free Survival
1
2009
191
0.040
Why?
Dose-Response Relationship, Radiation
2
1995
205
0.040
Why?
Pseudopodia
1
2007
10
0.040
Why?
Feasibility Studies
1
2007
189
0.040
Why?
Neoplasm Invasiveness
1
2007
150
0.030
Why?
Survival
1
2006
4
0.030
Why?
Microscopy, Fluorescence
1
2007
257
0.030
Why?
Cell Communication
1
2007
135
0.030
Why?
Chemistry, Pharmaceutical
1
2006
21
0.030
Why?
Dogs
1
2006
465
0.030
Why?
Infant, Newborn
1
2010
1772
0.030
Why?
Magnetic Resonance Imaging
1
2010
928
0.030
Why?
Cell Proliferation
1
2007
480
0.030
Why?
Ribonucleoprotein, U1 Small Nuclear
1
2000
2
0.020
Why?
Gliosarcoma
1
2000
4
0.020
Why?
Esophagitis
1
2000
11
0.020
Why?
Proto-Oncogene Proteins c-met
1
2000
15
0.020
Why?
Radiation Pneumonitis
1
2000
37
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2000
114
0.020
Why?
RNA, Catalytic
1
2000
58
0.020
Why?
Gene Transfer Techniques
1
2000
145
0.020
Why?
Neoplasm Staging
1
2000
326
0.020
Why?
Protein-Tyrosine Kinases
1
2000
164
0.020
Why?
Regression Analysis
1
2000
489
0.020
Why?
Palliative Care
1
2000
151
0.020
Why?
Carcinoma, Squamous Cell
1
2000
230
0.020
Why?
Survival Rate
1
2000
584
0.020
Why?
Recombinant Proteins
1
2000
706
0.020
Why?
Craniotomy
1
1997
16
0.020
Why?
Adenocarcinoma
1
2000
431
0.020
Why?
Confidence Intervals
1
1997
155
0.020
Why?
Matched-Pair Analysis
1
1995
17
0.020
Why?
Length of Stay
1
1997
284
0.020
Why?
Prevalence
1
1997
530
0.020
Why?
Remission Induction
1
1995
155
0.020
Why?
Predictive Value of Tests
1
1997
579
0.020
Why?
Incidence
1
1997
644
0.020
Why?
Tumor Stem Cell Assay
1
1994
22
0.010
Why?
Medulloblastoma
1
1994
17
0.010
Why?
Cerebellar Neoplasms
1
1994
19
0.010
Why?
Severity of Illness Index
1
1997
878
0.010
Why?
Risk Factors
1
1997
2172
0.010
Why?

Visualizations


Walter's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department